Aspire Biopharma Holdings Inc.(ASBP)
盘后0.2319-0.01-5.35%18:27 EDT
0.2450+0.0400+19.51%
行情数据延迟15分钟
- 最新
- 推荐
暂无内容公司概况
公司名称Aspire Biopharma Holdings Inc.所属市场NASDAQ成立日期- -员工人数- -办公地址- -邮政编码- -联系电话- -联系传真- -公司概况Aspire Biopharma Holdings, Inc.成立于2021年2月9日，是一家特拉华州公司。该公司是一家早期生物制药公司，从事开发和营销新型递送机制颠覆性技术的业务，最初用于“不伤害”药物。迄今为止，Aspire已开发并获得了颠覆性技术，这些技术是一种新型可溶性制剂，旨在解决紧急情况、药物功效、剂量管理和响应时间等问题。Aspire的重点是开发任何数量的可溶性、PH中性、速效粉末或颗粒形式的产品，允许产品的快速舌下吸收。- 04-20Form 8-K - Current report重要事件披露Form 8-K - Current report
- 04-17Form 8-K/A - Current report: [Amend]重要事件披露Form 8-K/A - Current report: [Amend]
- 04-16Form 8-K - Current report重要事件披露Form 8-K - Current report
- 04-16Form 8-K - Current report重要事件披露Form 8-K - Current report
- 04-16Form 8-K - Current report重要事件披露Form 8-K - Current report
- 04-15Form 8-K - Current report重要事件披露Form 8-K - Current report
- 04-10Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend][修订]招股说明书Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
- 04-08Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend][修订]年度报告Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
- 03-31Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]年度报告Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
- 02-18Form S-1 - General form for registration of securities under the Securities Act of 1933招股说明书Form S-1 - General form for registration of securities under the Securities Act of 1933
- 02-12Form 8-K - Current report重要事件披露Form 8-K - Current report
- 02-06Form 8-K - Current report重要事件披露Form 8-K - Current report
- 01-30Form 8-K - Current report重要事件披露Form 8-K - Current report
- 01-15Form 8-K - Current report重要事件披露Form 8-K - Current report
- 01-14Form 8-K - Current report重要事件披露Form 8-K - Current report
- 分时
- 5日
- 日
- 周
- 月
数据加载中...
最高
0.3100
今开
0.2480
量比
3.60
最低
0.2108
昨收
0.2050
换手率
6815.22%